Not applicableStudy completedNCT01833325What this trial is testingProton Radiation Therapy for Macular DegenerationWho this might be right forAge-Related Macular Degeneration University of Florida 9
Large-scale testing (Phase 3)Ended earlyNCT00433017What this trial is testingVerteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)Who this might be right forMacular DegenerationChoroidal Neovascularization Novartis 255
Not applicableStudy completedNCT00845273What this trial is testingLong-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular DegenerationWho this might be right forMacular Degeneration Pfizer 3,538
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Ended earlyNCT00090532What this trial is testingThe Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Pfizer 155
Early research (Phase 1)Study completedNCT00503022What this trial is testingSafety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular DegenerationWho this might be right forWet Age-Related Macular Degeneration Novartis 20
Large-scale testing (Phase 3)UnknownNCT00157976What this trial is testingDouble-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular DegenerationWho this might be right forMacular Degeneration Miravant Pharmaceuticals 660
Large-scale testing (Phase 3)Ended earlyNCT01940900What this trial is testingSafety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® MonotherapyWho this might be right forAge-Related Macular Degeneration Ophthotech Corporation 627
Testing effectiveness (Phase 2)UnknownNCT00032396What this trial is testingEvaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular DegenerationWho this might be right forMacular Degeneration Control Delivery Systems
Large-scale testing (Phase 3)Study completedNCT00150202What this trial is testingClinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)Who this might be right forMacular Degeneration Pfizer 90
Large-scale testing (Phase 3)Study completedNCT00090623What this trial is testingRhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Genentech, Inc. 180
Testing effectiveness (Phase 2)Study completedNCT00087763What this trial is testingPegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)Who this might be right forMacular Degeneration Eyetech Pharmaceuticals 135
Large-scale testing (Phase 3)Study completedNCT00429962What this trial is testingStudy Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVWho this might be right forChoroidal NeovascularizationAge-Related Macular Degeneration University Hospital, Basel, Switzerland 40
Testing effectiveness (Phase 2)Study completedNCT01175395What this trial is testing20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-Related Macular DegenerationChoroidal Neovascularization University of Illinois at Chicago 10
Testing effectiveness (Phase 2)Study completedNCT00138632What this trial is testingSafety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forWet Age-Related Macular Degeneration Novartis 50
Testing effectiveness (Phase 2)UnknownNCT00809419What this trial is testingThe NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF TherapyWho this might be right forAge Related Macular Degeneration NeoVista 32
Large-scale testing (Phase 3)Ended earlyNCT00139282What this trial is testingA Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular DegenerationWho this might be right for"Wet" Age-Related Macular Degeneration Genaera Corporation
Testing effectiveness (Phase 2)Study completedNCT00259753What this trial is testingSafety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular DegenerationWho this might be right forMacular Degeneration OPKO Health, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT02387957What this trial is testingA 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)Who this might be right forAge-Related Macular Degeneration Ophthotech Corporation 63
Testing effectiveness (Phase 2)Study completedNCT00211484What this trial is testingTreatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.Who this might be right forAge-Related Macular Degenerations.Subfoveal Neovascularization. Manhattan Eye, Ear & Throat Hospital 5